Valerie Malyvanh Jansen - 19 Oct 2021 Form 3 Insider Report for Elevation Oncology, Inc. (ELEV)

Role
Chief Medical Officer
Signature
/s/ Joseph Ferra, Attorney-in-Fact
Issuer symbol
ELEV
Transactions as of
19 Oct 2021
Net transactions value
$0
Form type
3
Filing time
21 Oct 2021, 18:29:06 UTC
Next filing
16 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ELEV Employee Stock Option (Right to Buy) 19 Oct 2021 Common Stock 158,654 $3.09 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 25% of the total shares on April 19, 2022, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.